STAMFORD, Conn., June 10 /PRNewswire-FirstCall/ -- Zargis Medical
Corp., a majority-owned subsidiary of Speedus Corp. (Nasdaq: SPDE),
today announced that its Zargis Cardioscan heart sounds analysis
software and the compatible 3M™ Littmann® Electronic Stethoscope
Model 3200 jointly received the highest honor—a Gold Award—as part
of the 2010 Medical Design Excellence Award competition.
The Medical Design Excellence Award competition recognizes
contributions and advances in the design of medical products.
Entries were evaluated on the basis of their design and engineering
features, including innovative use of materials, user-related
functions that improve healthcare delivery and change traditional
medical attitudes or practices, features that provide enhanced
benefits to the patient, and the ability of the product development
team to overcome design and engineering challenges so that the
product meets its clinical objectives.
The novel stethoscope/software system, which was named 2009
Popular Science "Innovation of the Year", also received
top-honors in the Electronics and Computers category of the
prestigious 2010 Edison Award competition.
The 2010 Medical Design Excellence Award winners were announced
and honored at a June 9 ceremony
during the Medical Design & Manufacturing (MD&M) East
Conference and Exposition in New
York.
About Zargis Medical Corp.
Zargis is a global medical device company focused on improving
health outcomes and cost-effectiveness through diagnostic support
software and innovation. Zargis is majority-owned by Speedus
Corp. (Nasdaq: SPDE), and both 3M Company and Siemens Corporate
Research, a division of Siemens AG (NYSE: SI), hold equity
positions.
For additional information about Zargis or Speedus Corp.,
contact Peter Hodge at 888.773.3669
(ext. 23) or phodge@zargis.com, or visit the following Web sites:
www.zargis.com and www.speedus.com.
Statements contained herein that are not historical facts,
including but not limited to statements about the Company's
product, corporate identity and focus, may be forward-looking
statements that are subject to a variety of risks and
uncertainties. There are a number of important factors that could
cause actual results to differ materially from those expressed in
any forward-looking statements made by the Company, including, but
not limited to, the continuing development of the Company's sales,
marketing and support efforts.
SOURCE Speedus Corp.
